ScoreWhy is Lincoln Pharmaceuticals Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 9.06% and Operating profit at 5.80% over the last 5 years
2
Negative results in Dec 24
- PBT LESS OI(Q) At Rs 19.71 cr has Fallen at -26.15%
- PAT(Q) At Rs 20.77 cr has Fallen at -25.9%
- ROCE(HY) Lowest at 19.61%
3
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated 2.52% returns since then
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Lincoln Pharma. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Lincoln Pharma.
-8.1%
-0.18
47.79%
SENSEX
0.45%
0.03
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.06%
EBIT Growth (5y)
5.80%
EBIT to Interest (avg)
53.83
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.05
Tax Ratio
22.39%
Dividend Payout Ratio
4.12%
Pledged Shares
0
Institutional Holding
5.16%
ROCE (avg)
23.54%
ROE (avg)
15.30%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
12
Industry P/E
33
Price to Book Value
1.69
EV to EBIT
10.92
EV to EBITDA
9.47
EV to Capital Employed
1.99
EV to Sales
1.48
PEG Ratio
4.99
Dividend Yield
NA
ROCE (Latest)
19.67%
ROE (Latest)
15.12%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-8What is not working for the Company
PBT LESS OI(Q)
At Rs 19.71 cr has Fallen at -26.15%
PAT(Q)
At Rs 20.77 cr has Fallen at -25.9%
ROCE(HY)
Lowest at 19.61%
Loading Valuation Snapshot...
Here's what is not working for Lincoln Pharma.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 19.71 cr has Fallen at -26.15%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 20.77 cr has Fallen at -25.9%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
